The Global Immunology Drugs Market size is expected to grow from USD 4.4 billion in 2021, to reach USD 6.6 billion by 2028, at a CAGR of 5.7% during the forecast period (2021 - 2028). The growth in this market can be attributed to the increased prevalence of autoimmune diseases and cancer, as well as advancements in treatment methods for patients with these conditions.
Immunology Drugs are a group of medicines that work to treat or control the body's immune system. These treatments can be administered as either intravenous medications, oral tablets, injections, or topical creams (e.g., ointments). Immunology drugs have a range of uses including treating autoimmune diseases and cancer cells in order to help manage symptoms related to these conditions.
On the basis of Types, the market is segmented into Monoclonal Antibodies (mAb), Antibody Drug Conjugates, Interferon and Cytokine Therapies, Immunosuppressive Medication.
Monoclonal Antibodies are a type of antibody that is produced by the immune system in response to an antigen. They mainly work as part of what’s called “the adaptive immune response,” which includes cells like B and T lymphocytes, macrophages, natural killer cells, and dendritic cells. These antibodies attach themselves to antigens for identification purposes before triggering other parts of the body's immune system to attack those antigens. The human body produces monoclonal antibodies naturally - they're not made synthetically or from animal sources (such as rabbits).
Antibody-Drug Conjugates is a type of antibody-based drug that includes one or more drugs covalently attached to the protein carrier. It induces antibodies to bind with cancer cells, which leads to their destruction both in vitro and in vivo as they are internalized by tumor cells and released from them through lysosomal mechanisms.
Interferon and Cytokine therapies are broadly divided into two categories: biological agents (interferons) and chemical agents (cytokines). Biological agents, such as subcutaneous photopheresis, T-cell therapy, or peritoneal dialysis with an immunosuppressant agent for kidney transplantation, have been in use to treat autoimmune diseases.
On the other hand, cytokines are used mainly in cancer treatment. They can be administered directly to a tumor site by injection or intravenously; alternatively, they may act indirectly on nearby cells by increasing their sensitivity to radiation therapy. Examples of these include GM-CSF which is used for many types of cancers including multiple myeloma and leukemia.
The word "immunosuppressive" refers to a medication that suppresses the immune system. The aim of these drugs is usually to inhibit or prevent an overreaction of the body's immune response, such as in autoimmune disorders and transplant rejection. Immunosuppressive drugs are also used for chemotherapy patients who have undergone bone marrow transplants.
On the basis of Application, the market is segmented into Hospitals, Clinics, and Cancer Research Centers & Institutes. Hospitals are expected to have a higher market share than clinics for the forecast period. The main reason can be attributed to hospitals being more equipped with advanced equipment needed for treatment procedures which are not available in most clinics.
Hospitals are the most active players in this industry. The growing demand for Immunology Drugs is a reflection of their increasing use among hospital patients to treat cancer, immunodeficiency disorders, and autoimmune diseases. Moreover, hospitals also provide chemotherapy sessions using these drugs to reduce toxic side effects on the body tissues and blood cells that may be caused by chemotherapy drugs which can become fatal if not dealt with timely enough.
On the basis of Region, the market is segmented ed into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for nearly one-third of the global cancer research centers and institutes segment due to greater awareness about various skin cancers among patients as well as its high incidence rate. The major reason behind this can be attributed to the increasing incidence rates of various skin cancers among patients coupled with greater awareness about it by people living in the US & Canada. Latin America has been witnessing steady growth over recent years and is expected to be the fastest-growing region for immunology drugs in the coming years.
Up Market Research published a new report titled “Immunology Drug Market research report which is segmented by Types (Monoclonal Antibodies (mAb), Antibody Drug Conjugates, Interferon and Cytokine therapies, Immunosuppressive medication), By Applications (Hospitals, Clinics, Cancer Research Centers and Institutes), By Players/Companies Abbott Laboratories, Active Biotech, Eli Lilly and Company, Autoimmune Inc., Pfizer, GlaxoSmithKline plc, Seattle Genetics, Genentech, F. Hoffmann-La Roche Ltd., Eisai Co., Bayer AG, Sanofi Aventis LLC.”.
|Report Attributes||Report Details|
|Report Title||Immunology Drug Market Research Report|
|By Type||Monoclonal Antibodies (mAb), Antibody Drug Conjugates, Interferon and Cytokine therapies, Immunosuppressive medication|
|By Application||Hospitals, Clinics, Cancer Research Centers and Institutes|
|By Companies||Abbott Laboratories, Active Biotech, Eli Lilly and Company, Autoimmune Inc., Pfizer, GlaxoSmithKline plc, Seattle Genetics, Genentech, F. Hoffmann-La Roche Ltd., Eisai Co., Bayer AG, Sanofi Aventis LLC.|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||226|
|Number of Tables & Figures||159|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Monoclonal Antibodies (mAb), Antibody Drug Conjugates, Interferon and Cytokine therapies, Immunosuppressive medication and By Application Hospitals, Clinics, Cancer Research Centers and Institutes.
Some of the companies that are profiled in this report are:
Immunology Drug Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Immunology Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Immunology Drug Market Report:
Some other reports from this category!